Page 41 - Read Online
P. 41

Page 14 of 16                            Sugarbaker. J Cancer Metastasis Treat 2018;4:7  I  http://dx.doi.org/10.20517/2394-4722.2017.67


               14.  Landry J, Tepper JE, Wood WC, Moulton EO, Koerner F, Sullinger J. Patterns of failure following curative resection of gastric
                   carcinoma. Int J Radiat Oncol Biol Phys 1990;19:1357-62.
               15.  Wils J, Meyer HJ, Wilke H. Current status and future directions in the treatment of localized gastric cancer. Ann Oncol 1994;5 Suppl
                   3:69-72.
               16.  Maruyama K, Okabayashi K, Kinoshita T. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg
                   1987;11:418-25.
               17.  Kaibara N, Sumi K, Yonekawa M, Ohta M, Makino M, Kimura O, Nishidoi H, Koga S. Does extensive dissection of lymph nodes
                   improve the results of surgical treatment of gastric cancer? Am J Surg 1990;159:218-21.
               18.  Korenaga D, Moriguchi S, Orita H, Kakeji Y, Haraguchi M, Maehara Y, Sugimachi K. Trends in survival rates in Japanese patients with
                   advanced carcinoma of the stomach. Surg Gynecol Obstet 1992;174:387-93.
               19.  Boku T, Nakane Y, Minoura T, Takada H, Yamamura M, Hioki K, Yamamoto M. Prognostic significance of serosal invasion and free
                   intraperitoneal cancer cells in gastric cancer. Br J Surg 1990;77:436-9.
               20.  Fujimoto S, Takahashi M, Mutou T, Kobayashi K, Toyosawa T, Isawa E, Sumida M, Ohkubo H. Improved mortality rate of gastric
                   carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery.
                   Cancer 1997;79:884-91.
               21.  Kodera Y, Yamamura Y, Shimizu Y, Torii A, Hirai T, Yasui K, Morimoto T, Kato T. Peritoneal washing cytology: prognostic value of
                   positive findings in patients with gastric carcinoma undergoing a potentially curative resection. J Surg Oncol 1999;72:60-4; discussion
                   64-5.
               22.  Bando E, Yonemura Y, Takeshita Y, Taniguchi K, Yasui T, Yoshimitsu Y, Fushida S, Fujimura T, Nishimura G, Miwa K. Intraoperative
                   lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg 1999;178:256-62.
               23.  Fujimura T, Yonemura Y, Ninomiya I, Miwa K, Miyazaki I, Endo Y, Ishikawa N, Obata T, Tanaka M, Sasaki T. Early detection of
                   peritoneal dissemination of gastrointestinal cancers by reverse-transcriptase polymerase chain reaction. Oncol Rep 1997;4:1015-9.
               24.  Marutsuka T, Shimada S, Shiomori K, Hayashi N, Yagi Y, Yamane T, Ogawa M. Mechanisms of peritoneal metastasis after operation for
                   non-serosa-invasive gastric carcinoma: an ultrarapid detection system for intraperitoneal free cancer cells and a prophylactic strategy for
                   peritoneal metastasis. Clin Cancer Res 2003;9:678-85.
               25.  Takebayashi K, Murata S, Yamamoto H, Ishida M, Yamaguchi T, Kojima M, Shimizu T, Shiomi H, Sonoda H, Naka S, Mekata E, Okabe H,
                   Tani T. Surgery-induced peritoneal cancer cells in patients who have undergone curative gastrectomy for gastric cancer. Ann Surg Oncol
                   2014;21:1991-7.
               26.  Arita T, Ichikawa D, Konishi H, Komatsu S, Shiozaki A, Hiramoto H, Hamada J, Shoda K, Kawaguchi T, Hirajima S, Nagata H,
                   Fujiwara H, Okamoto K, Otsuji E. Increase in peritoneal recurrence induced by intraoperative hemorrhage in gastrectomy. Ann Surg
                   Oncol 2015;22:758-64.
               27.  Sethna KS, Sugarbaker PH. New prospects for the control of peritoneal surface dissemination of gastric cancer using perioperative
                   intraperitoneal chemotherapy. Cancer Ther 2004;2:79-84.
               28.  Los G, Mutsaers PH, Lenglet WJ, Baldew GS, McVie JG. Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin
                   treatment. Cancer Chemother Pharmacol 1990;25:389-94.
               29.  Xu DZ, Zhan YQ, Sun XW, Cao SM, Geng QR. Meta-analysis of intraperitoneal chemotherapy for gastric cancer. World J Gastroenterol
                   2004;10:2727-30.
               30.  Yan TD, Black D, Sugarbaker PH, Zhu J, Yonemura Y, Petrou G, Morris DL. A systematic review and meta-analysis of the randomized
                   controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 2007;14:2702-13.
               31.  Feingold PL, Kwong ML, Sabesan A, Sorber R, Rudloff U. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for
                   gastric cancer and other less common disease histologies: is it time? J Gastrointest Oncol 2016;7:87-98.
               32.  Yonemura Y, Kawamura T, Bandou E, Takahashi S, Sawa T, Matsuki N. Treatment of peritoneal dissemination from gastric cancer by
                   peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 2005;92:370-5.
               33.  Glehen O, Gilly FN, Arvieux C, Cotte E, Boutitie F, Mansvelt B, Bereder JM, Lorimier G, Quenet F, Elias D; Association Française
                   de Chirurgie. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery
                   combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 2010;17:2370-7.
               34.  Hall JJ, Loggie BW, Shen P, Beamer S, Douglas Case L, McQuellon R, Geisinger KR, Levine EA. Cytoreductive surgery with
                   intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. J Gastrointest Surg 2004;8:454-63.
               35.  Yu W, Whang I, Chung HY, Averbach A, Sugarbaker PH. Indications for early postoperative intraperitoneal chemotherapy of advanced
                   gastric cancer: results of a prospective randomized trial. World J Surg 2001;25:985-90.
               36.  Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL, Faure JL, Porcheron J,
                   Peix JL, François Y, Vignal J, Gilly FN. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1
                   multicentric prospective study. Cancer 2000;88:358-63.
               37.  Boku N; Gastrointestinal Oncology Study Group of Japan Clinical Oncology Group. Chemotherapy for metastatic disease: review from
                   JCOG trials. Int J Clin Oncol 2008;13:196-200.
               38.  Hirose K, Katayama K, Iida A, Yamaguchi A, Nakagawara G, Umeda S, Kusaka Y. Efficacy of continuous hyperthermic peritoneal
                   perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: evaluation by multivariate regression
                   analysis. Oncology 1999;57:106-14.
               39.  Rossi CR, Pilati P, Mocellin S, Foletto M, Ori C, Innocente F, Nitti D, Lise M. Hyperthermic intraperitoneal intraoperative chemotherapy
                   for peritoneal carcinomatosis arising from gastric adenocarcinoma. Suppl Tumori 2003;2:S54-7.
               40.  Glehen O, Schreiber V, Cotte E, Sayag-Beaujard AC, Osinsky D, Freyer G, François Y, Vignal J, Gilly FN. Cytoreductive surgery and
                   intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg 2004;139:20-6.
               41.  Scaringi S, Kianmanesh R, Sabate JM, Facchiano E, Jouet P, Coffin B, Parmentier G, Hay JM, Flamant Y, Msika S. Advanced gastric
   36   37   38   39   40   41   42   43   44   45   46